Auchus RJ - Search Results

1

Molecular pathways: Inhibiting steroid biosynthesis in prostate cancer.

Ferraldeschi R, Sharifi N, Auchus RJ, Attard G. Ferraldeschi R, et al. Among authors: auchus rj. Clin Cancer Res. 2013 Jul 1;19(13):3353-9. doi: 10.1158/1078-0432.CCR-12-0931. Epub 2013 Mar 7. Clin Cancer Res. 2013. PMID: 23470964 Free PMC article. Review.

2

3beta-hydroxysteroid dehydrogenase is a possible pharmacological target in the treatment of castration-resistant prostate cancer.

Evaul K, Li R, Papari-Zareei M, Auchus RJ, Sharifi N. Evaul K, et al. Among authors: auchus rj. Endocrinology. 2010 Aug;151(8):3514-20. doi: 10.1210/en.2010-0138. Epub 2010 Jun 9. Endocrinology. 2010. PMID: 20534728

3

"Getting from here to there"--mechanisms and limitations to the activation of the androgen receptor in castration-resistant prostate cancer.

Sharifi N, McPhaul MJ, Auchus RJ. Sharifi N, et al. Among authors: auchus rj. J Investig Med. 2010 Dec;58(8):938-44. doi: 10.231/JIM.0b013e3181ff6bb8. J Investig Med. 2010. PMID: 21030877 Free PMC article. Review.

4

Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer.

Chang KH, Li R, Papari-Zareei M, Watumull L, Zhao YD, Auchus RJ, Sharifi N. Chang KH, et al. Among authors: auchus rj. Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13728-33. doi: 10.1073/pnas.1107898108. Epub 2011 Jul 27. Proc Natl Acad Sci U S A. 2011. PMID: 21795608 Free PMC article.

5

Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer.

Attard G, Reid AH, Auchus RJ, Hughes BA, Cassidy AM, Thompson E, Oommen NB, Folkerd E, Dowsett M, Arlt W, de Bono JS. Attard G, et al. Among authors: auchus rj. J Clin Endocrinol Metab. 2012 Feb;97(2):507-16. doi: 10.1210/jc.2011-2189. Epub 2011 Dec 14. J Clin Endocrinol Metab. 2012. PMID: 22170708 Clinical Trial.

6

Human steroid biosynthesis for the oncologist.

Auchus ML, Auchus RJ. Auchus ML, et al. Among authors: auchus rj. J Investig Med. 2012 Feb;60(2):495-503. doi: 10.2310/JIM.0b013e3182408567. J Investig Med. 2012. PMID: 22222232 Free PMC article. Review.

7

Steroid biosynthesis and prostate cancer.

Sharifi N, Auchus RJ. Sharifi N, et al. Among authors: auchus rj. Steroids. 2012 Jun;77(7):719-26. doi: 10.1016/j.steroids.2012.03.015. Epub 2012 Apr 5. Steroids. 2012. PMID: 22503713 Review.

8

Abiraterone inhibits 3β-hydroxysteroid dehydrogenase: a rationale for increasing drug exposure in castration-resistant prostate cancer.

Li R, Evaul K, Sharma KK, Chang KH, Yoshimoto J, Liu J, Auchus RJ, Sharifi N. Li R, et al. Among authors: auchus rj. Clin Cancer Res. 2012 Jul 1;18(13):3571-9. doi: 10.1158/1078-0432.CCR-12-0908. Clin Cancer Res. 2012. PMID: 22753664

9

A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer.

Chang KH, Li R, Kuri B, Lotan Y, Roehrborn CG, Liu J, Vessella R, Nelson PS, Kapur P, Guo X, Mirzaei H, Auchus RJ, Sharifi N. Chang KH, et al. Among authors: auchus rj. Cell. 2013 Aug 29;154(5):1074-1084. doi: 10.1016/j.cell.2013.07.029. Cell. 2013. PMID: 23993097 Free PMC article.

10

Androstenedione is the preferred androgen source in hormone refractory prostate cancer--letter.

Sharifi N, Auchus RJ. Sharifi N, et al. Among authors: auchus rj. Clin Cancer Res. 2014 Sep 15;20(18):4971. doi: 10.1158/1078-0432.CCR-14-1123. Clin Cancer Res. 2014. PMID: 25225065 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

340 results

Search Page